Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19

Rev Esp Cardiol (Engl Ed). 2021 Sep;74(9):812-814. doi: 10.1016/j.rec.2021.04.005. Epub 2021 Apr 27.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Myocarditis* / chemically induced
  • Myocarditis* / diagnosis
  • SARS-CoV-2
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines
  • BNT162 Vaccine